NSE filing, NSE: QUICKHEAL. Summary written from the filing by ALFA Finder's alert engine.
Quick Heal Technologies Ltd: key numbers
- Share price
- ₹137.73
- Market cap
- ₹747.5 Cr
- Revenue (annual)
- ₹261.0 Cr
- Net profit (annual)
- ₹-10.93 Cr
- P/E (TTM)
- -58.4×Sector 22.9×
- Promoter holding
- 71.46%-0.02% QoQ
- FII holding
- 0.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Quick Heal Technologies Ltd
All →Quick Heal Technologies Earnings Call Transcript: Key Takeaways
Quick Heal is pivoting from a declining B2C antivirus market to Enterprise cybersecurity (Seqrite), showing early signs of recovery.
- Call
- Guides 80% growth
Quick Heal Technologies Management Change
Quick Heal appointed Shailesh Shinde as Company Secretary and KMP effective October 27, 2026. The board also approved an internal auditor and nodal officer appointment.
Quick Heal Technologies Q2 FY27 Results: Net Profit ₹5.8 Cr, Down 26.6% YoY
Quick Heal Technologies Ltd reported revenue from operations of ₹64.9 Cr (-22.3% YoY) and net profit of ₹5.8 Cr (-26.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹5.8 Cr · -26.6% YoY
Quick Heal Technologies Board Meeting Date
Quick Heal Technologies Ltd will hold a board meeting on October 27, 2026, to approve unaudited financial results for the quarter ended September 30, 2026.
Quick Heal Technologies Other Announcement
Quick Heal Technologies Ltd has filed its quarterly Shareholding Pattern for the period ended September 30, 2026, as per SEBI regulations.
Quick Heal Technologies Management Change
Mr. Sarang Deshpande has resigned as Company Secretary and Key Managerial Personnel of Quick Heal Technologies Limited, effective on or before October 27, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date